MDVerse

Fremont, United States

MDVerse develops regenerative medicine for drug development, manufacturing, and clinical trials.

$750K raised

Jan 2023

Seed

Top Investors

PGV

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has MDVerse raised?

MDVerse has raised $750K in total funding. The most recent round was Seed. The last funding was announced in January 2023.

Who are MDVerse's investors?

MDVerse's investors include PGV.

Where is MDVerse headquartered?

MDVerse is headquartered in Fremont, United States.

What does MDVerse do?

MDVerse develops regenerative medicine for drug development, manufacturing, and clinical trials.

What stage is MDVerse at?

MDVerse is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 1, 2023.

MLA

"MDVerse — Funding & Investors." VCBacked, January 1, 2023, https://www.vcbacked.co/company/mdverse. Accessed June 17, 2026.

APA

VCBacked. (2023). MDVerse — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/mdverse

Wikipedia (cite web)

{{cite web |title=MDVerse — Funding & Investors |url=https://www.vcbacked.co/company/mdverse |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 1, 2023.